Yes, the need is urgent. The blocking of the bill is problematic, because people desperately need these medications. It's important that we act expeditiously.
With respect to the committee of experts, the intention would be to immediately name the folks who would populate that committee and for it to be able to report back so that we can get clear and concise information around costs and options on the path forward.
While this work we're doing now is essential in the areas of diabetes and contraceptives, we know there's a lot more work to be done. That committee, I think, is going to be very important in instructing costs and process in the way forward.